NOTRELOAD AI
  • NOTRELOAD AI
  • myNOTRELOAD
  • One-Time License
  • Invest ↗
  • XY Feed
  • Push Notifications
Sign in Subscribe

Bolt Bio & NewAmsterdam Get Buy Ratings from H.C. Wainwright

H.C. Wainwright initiates coverage on Bolt Biotherapeutics and NewAmsterdam Pharma with Buy ratings, highlighting innovative treatments in development.

Bolt Bio & NewAmsterdam Get Buy Ratings from H.C. Wainwright
Credit: Bolt Biotherapeutics
Already have an account? Sign in.
10/20/2025 · 10:53 AM
BOLT
/ Don’t stop at just one post.

Related↓

Bolt Biotherapeutics Merges with Prana Therapies, Secures $120M to Fund Inflammatory Pipeline
10/23/2026 · 12:14 PM

Bolt Biotherapeutics Merges with Prana Therapies, Secures $120M to Fund Inflammatory Pipeline

Bolt Biotherapeutics merges with Prana Therapies in a $120 million deal to advance PRA-216 through Phase 2 trials in asthma, COPD, and atopic dermatitis.

/ Subscriber only
/ Read more

Feed↓

Abivax Stock Drops After Short-Seller Calls Its Main Drug Toxic
Featured/ 11/20/2026 · 5:27 PM

Abivax Stock Drops After Short-Seller Calls Its Main Drug Toxic

Abivax shares fell after Scorpion Capital claimed its ulcerative colitis drug is toxic. The company rejected the report and reaffirmed its Phase 3 data.

/ Subscriber only
CrowdStrike Explores Acquisition of Zscaler in Major Cybersecurity Consolidation
Featured/ 11/20/2026 · 4:55 PM

CrowdStrike Explores Acquisition of Zscaler in Major Cybersecurity Consolidation

CrowdStrike is reportedly in talks to acquire Zscaler in a potential $265 billion cybersecurity deal, one of the largest in the sector.

/ Subscriber only
Canadian Solar Stock Tumbles on Report of Advisors Exploring Asset Sales and Bankruptcy
11/20/2026 · 3:40 PM

Canadian Solar Stock Tumbles on Report of Advisors Exploring Asset Sales and Bankruptcy

Canadian Solar shares fell sharply after a report that the solar firm and its Recurrent Energy unit are considering asset sales and a possible Chapter 11 filing.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • myNOTRELOAD
  • One-Time License
  • Invest ↗
  • XY Feed
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI